Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Synthesis, activity and use of NK1/NK2 receptor antagonists reported by AstraZeneca

Aug. 1, 2000

AstraZeneca presents novel antiinflammatory compounds for asthma, etc.

July 28, 2000

Maxygen and Karolinska Institute to develop novel allergy therapeutics

July 28, 2000

Fujisawa presents new benzimidazoles active as bradykinin antagonists

July 27, 2000

Interactions between alcohol and rupatadine examined in humans

July 27, 2000

Preparation and use of new lactams as inhibitors of serine proteases, antibiotics

July 26, 2000

Imperial College Innovations launches company for allergy therapies

July 26, 2000

Chemokine CCR3 receptor modulators claimed by DuPont in recent patent literature

July 25, 2000

BCY Ventures selects lead compound for CF therapy

July 25, 2000

Inhaled furosemide reduces experimental dyspnea in humans

July 25, 2000

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...